ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC
Article in International Immunopharmacology (August 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (August 2024)
Article in BMC Cancer (August 2024)
Article in Computers in Biology and Medicine (May 2024)